Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Spyre Therapeutics (SYRE) Asset Utilization Ratio (2016 - 2023)

Historic Asset Utilization Ratio for Spyre Therapeutics (SYRE) over the last 8 years, with Q1 2024 value amounting to 0.0.

  • Spyre Therapeutics' Asset Utilization Ratio fell 9120.02% to 0.0 in Q1 2024 from the same period last year, while for Mar 2024 it was 0.0, marking a year-over-year decrease of 9120.02%. This contributed to the annual value of 0.0 for FY2023, which is 8332.15% down from last year.
  • According to the latest figures from Q1 2024, Spyre Therapeutics' Asset Utilization Ratio is 0.0, which was down 9120.02% from 0.0 recorded in Q4 2023.
  • In the past 5 years, Spyre Therapeutics' Asset Utilization Ratio registered a high of 0.3 during Q1 2022, and its lowest value of 0.0 during Q1 2024.
  • For the 4-year period, Spyre Therapeutics' Asset Utilization Ratio averaged around 0.09, with its median value being 0.04 (2022).
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first soared by 14033.62% in 2022, then crashed by 9553.18% in 2023.
  • Over the past 4 years, Spyre Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.23 in 2021, then plummeted by 87.63% to 0.03 in 2022, then tumbled by 88.73% to 0.0 in 2023, then tumbled by 48.59% to 0.0 in 2024.
  • Its last three reported values are 0.0 in Q1 2024, 0.0 for Q4 2023, and 0.0 during Q3 2023.